Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

David R Compton

3PUBLICATIONS
8CO-AUTHORS
Liquid biopsiesAutomotive mechatronics and autonomous systemsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 20, 2024
Weight of Evidence: Is an Animal Study Warranted? Assessments for Carcinogenicity, Drug Abuse Liability, and Pediatric Safety.

Thulasi Ramani, Ronald L Wange, T Scott Manetz

|Dec 06, 2022
AAV2-hAADC (Eladocagene Exuparvovec) Biodistribution and Expression: Superiority of Intraputaminal versus Intracerebroventricular and Intrathecal (Lumbar) Routes of Administration.

David R Compton, Steven J DeMarco, Padmaja Yalamanchili

|Aug 23, 2021
Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease.

Paul Wuh-Liang Hwu, Karl Kiening, Irina Anselm

Pageof 1

Frequent Collaborators

1 joint publications

Paul Wuh-Liang Hwu

1 joint publications

Irina Anselm

1 joint publications

Thomas Opladen

1 joint publications

Phillip L Pearl

1 joint publications

Agathe Roubertie

1 joint publications

Shin-Ichi Muramatsu

1 joint publications

Thulasi Ramani

1 joint publications

Ronald L Wange

Frequent Collaborators

1 joint publications

Paul Wuh-Liang Hwu

1 joint publications

Irina Anselm

1 joint publications

Thomas Opladen

1 joint publications

Phillip L Pearl

Top Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on : May 10, 2016

12.2K
Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice
08:17

Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice

Published on : Feb 15, 2019

37.5K
Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on : Feb 28, 2016

13.5K
See more related videos

Top Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on : May 10, 2016

12.2K
Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice
08:17

Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice

Published on : Feb 15, 2019

37.5K
Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on : Feb 28, 2016

13.5K
See more related videos